Previous studies have demonstrated that hyperinsulinemia reduces osteoblast activity via upregulation of transforming growth factor-β (TGF-β) and is associated with decreased bone metabolism-related gene expression, which subsequently impairs trabecular micro-architecture [20, 21]. Here, TGFB1 is linked to hyperinsulinism.